[Significance of free fatty acid levels in evaluating the severity of myocardial infarction and the efficacy of drug therapy].
D000208:Acute Disease; D001145:Arrhythmias, Cardiac / Q000209:etiology; D002395:Catecholamines / Q000097:blood; D003000:Clonidine / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood* / Q000378:metabolism; D005500:Follow-Up Studies; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy / Q000628:therapy; D009206:Myocardium / Q000378:metabolism; D009458:Neuroleptanalgesia; D009539:Nicotinic Acids / Q000627:therapeutic use; D010101:Oxygen Consumption; D013997:Time Factors
D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D006493:Heparin; D003000:Clonidine
Znachenie urovnia svobodnykh zhirnykh kislot v otsenke tiazhesti infarkta miokarda i éffektivnosti medikamentoznoĭ terapii.